multiple sclerosis peptide therapy (ImmuLogic)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namemultiple sclerosis peptide therapy (ImmuLogic)
Drug Alias Namemyelin basic protein agonist peptides (Immulogic/Schering AG)MBP peptides (Immulogic/Schering AG)
ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmulogic
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmulogicBayer Schering Pharma AG
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A